[Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].

Abstract

In a multicentre, single-blind study, the bronchospasmolytic effect of a single oral dose of tulobuterol 2.0 mg and of fenoterol 2.5 mg was compared in 26 patients suffering from reversible airways obstruction. The bronchospasmolysis achieved with the oral application of tulobuterol and fenoterol is qualitatively satisfactory and reliable, the effect of tulobuterol persisting for a longer period than that of fenoterol.

• Authors: H Morr, M Nink, R Ferlinz
• Journal: Pneumologie (Stuttgart, Germany) (Pneumologie) Vol. 44 Issue 4 Pg. 739-43 (Apr 1990) ISSN: 0934-8387 [Print] Germany
• Vernacular Title: Orale Therapie mit Beta-2-Sympathomimetika: Vergleichende Studie zur bronchospasmolytischen Wirkung von Tulobuterol und Fenoterol bei Patienten mit reversibler Atemwegsobstruktion.
• PMID: 2192369 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Bronchodilator Agents
• Fenoterol
• tulobuterol
• Terbutaline

Topics

• Administration, Oral
• Adult
• Aged
• Airway Resistance (drug effects)
• Bronchodilator Agents (administration & dosage)
• Fenoterol (administration & dosage)
• Forced Expiratory Volume (drug effects)
• Humans
• Lung Diseases, Obstructive (drug therapy)
• Middle Aged
• Randomized Controlled Trials as Topic
• Terbutaline (administration & dosage, analogs & derivatives)